BioSpace News Archive

Sartorius has supported CanSino Biologics Inc. and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials.

The two companies will work to develop up to four preclinical compounds discovered by Sitryx for autoimmune diseases.

On Monday, a judge ruled against patents blocking the way for generic drugmakers Hikma Pharmaceuticals and Dr. Reddy’s Laboratories to file Abbreviated New Drug Applications for Vascepa generics.

“The adjustments we have made to our studies reflect our foremost concern for the safety and well-being of study participants, clinical investigators and their site staffs, our employees and communities as we face this challenging and unpredictable operating environment,” said Warren Huff, Reata’s chief executive officer and president.

In addition to the impact on conferences and large meetings, many companies have implemented restrictions on face-to-face meetings between sales reps and clients.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.

Under terms of the agreement, Charles River Laboratories will be able to provide its clients with the use of Deciphex’s flagship product.

Here are four ways to improve your productivity while working from home!

Results from the trial, which will begin dosing on April 6, aren’t likely until September.

Collaboration with Silence Therapeutics aims to develop novel, targeted treatments to address significant unmet need